PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results
- PMID: 17124629
- DOI: 10.1007/s10822-006-9087-6
PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results
Abstract
We introduce PHASE, a highly flexible system for common pharmacophore identification and assessment, 3D QSAR model development, and 3D database creation and searching. The primary workflows and tasks supported by PHASE are described, and details of the underlying scientific methodologies are provided. Using results from previously published investigations, PHASE is compared directly to other ligand-based software for its ability to identify target pharmacophores, rationalize structure-activity data, and predict activities of external compounds.
Similar articles
-
Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.Proteins. 2008 Dec;73(4):889-901. doi: 10.1002/prot.22115. Proteins. 2008. PMID: 18536013
-
Towards a MIP-based alignment and docking in computer-aided drug design.Proteins. 2004 Aug 15;56(3):585-94. doi: 10.1002/prot.20153. Proteins. 2004. PMID: 15229890
-
Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach.J Med Chem. 2004 Aug 12;47(17):4258-67. doi: 10.1021/jm040769c. J Med Chem. 2004. PMID: 15293997
-
QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity.Expert Opin Drug Discov. 2015 Jan;10(1):37-51. doi: 10.1517/17460441.2015.968123. Epub 2014 Oct 9. Expert Opin Drug Discov. 2015. PMID: 25297377 Review.
-
Molecular docking towards drug discovery.J Mol Recognit. 1996 Mar-Apr;9(2):175-86. doi: 10.1002/(sici)1099-1352(199603)9:2<175::aid-jmr260>3.0.co;2-d. J Mol Recognit. 1996. PMID: 8877811 Review.
Cited by
-
Enhanced ranking of PknB Inhibitors using data fusion methods.J Cheminform. 2013 Jan 14;5(1):2. doi: 10.1186/1758-2946-5-2. J Cheminform. 2013. PMID: 23317154 Free PMC article.
-
DrugOn: a fully integrated pharmacophore modeling and structure optimization toolkit.PeerJ. 2015 Jan 13;3:e725. doi: 10.7717/peerj.725. eCollection 2015. PeerJ. 2015. PMID: 25648563 Free PMC article.
-
Identification of PPARgamma partial agonists of natural origin (I): development of a virtual screening procedure and in vitro validation.PLoS One. 2012;7(11):e50816. doi: 10.1371/journal.pone.0050816. Epub 2012 Nov 30. PLoS One. 2012. PMID: 23226391 Free PMC article.
-
Discovery of small molecule inhibitors to Krüppel-like factor 10 (KLF10): implications for modulation of T regulatory cell differentiation.J Med Chem. 2015 Feb 12;58(3):1466-78. doi: 10.1021/jm5018187. Epub 2015 Feb 4. J Med Chem. 2015. PMID: 25581017 Free PMC article.
-
Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor.Int J Mol Sci. 2024 Jan 22;25(2):1358. doi: 10.3390/ijms25021358. Int J Mol Sci. 2024. PMID: 38279359 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources